SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ng9'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_W_CHDW4060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.83A	1v54N-3ng9A: undetectable 1v54W-3ng9A: undetectable	1v54N-3ng9A: 21.77 1v54W-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VIF_A_FOLA1_0 (DIHYDROFOLATE REDUCTASE)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	3 / 3	GLN A 259 ILE A 260 TYR A 276	None	0.72A	1vifA-3ng9A: undetectable	1vifA-3ng9A: 6.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.87A	2dyrN-3ng9A: undetectable 2dyrW-3ng9A: undetectable	2dyrN-3ng9A: 21.77 2dyrW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.85A	2eijN-3ng9A: undetectable 2eijW-3ng9A: undetectable	2eijN-3ng9A: 21.77 2eijW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.92A	2eikN-3ng9A: undetectable 2eikW-3ng9A: undetectable	2eikN-3ng9A: 21.77 2eikW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.91A	2eilN-3ng9A: undetectable 2eilW-3ng9A: undetectable	2eilN-3ng9A: 21.77 2eilW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PLW_A_SAMA203_1 (RIBOSOMAL RNA METHYLTRANSFERASE, PUTATIVE)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	3 / 3	SER A 526 ASP A 529 ASP A 532	None	0.79A	2plwA-3ng9A: undetectable	2plwA-3ng9A: 13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VQY_A_PARA1201_2 (AAC(6')-IB)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	3 / 3	TRP A 280 GLN A 646 TRP A 247	None	1.37A	2vqyA-3ng9A: undetectable	2vqyA-3ng9A: 13.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.91A	3ablA-3ng9A: undetectable 3ablJ-3ng9A: undetectable	3ablA-3ng9A: 21.77 3ablJ-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.93A	3ablN-3ng9A: undetectable 3ablW-3ng9A: undetectable	3ablN-3ng9A: 21.77 3ablW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.89A	3ag3A-3ng9A: undetectable 3ag3J-3ng9A: undetectable	3ag3A-3ng9A: 21.77 3ag3J-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_W_CHDW1059_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.87A	3asnN-3ng9A: undetectable 3asnW-3ng9A: undetectable	3asnN-3ng9A: 21.77 3asnW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_D_CAMD502_0 (CAMPHOR 5-MONOOXYGENASE)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 5	PHE A 292 LEU A 687 GLY A 306 VAL A 612	None	1.04A	3wrkD-3ng9A: undetectable	3wrkD-3ng9A: 18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2V_A_BZ1A302_1 (CARBONIC ANHYDRASE 2)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	5 / 12	LEU A 355 GLN A 646 VAL A 354 GLY A 361 THR A 278	None	0.94A	4m2vA-3ng9A: undetectable	4m2vA-3ng9A: 14.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.41A	4v2yA-3ng9A: undetectable	4v2yA-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.41A	4v2yB-3ng9A: undetectable	4v2yB-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_A_Y70A151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.43A	4v2zA-3ng9A: undetectable	4v2zA-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_B_Y70B151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.39A	4v2zB-3ng9A: undetectable	4v2zB-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_A_LVYA151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.42A	4v30A-3ng9A: undetectable	4v30A-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_B_LVYB151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.33A	4v30B-3ng9A: undetectable	4v30B-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMH_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.47A	5amhA-3ng9A: undetectable	5amhA-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.42A	5amiA-3ng9A: undetectable	5amiA-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.44A	5amiB-3ng9A: undetectable	5amiB-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMJ_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.42A	5amjA-3ng9A: undetectable	5amjA-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMJ_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.40A	5amjB-3ng9A: undetectable	5amjB-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMK_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.37A	5amkB-3ng9A: undetectable	5amkB-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.85A	5b1bA-3ng9A: undetectable 5b1bJ-3ng9A: undetectable	5b1bA-3ng9A: 21.77 5b1bJ-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.84A	5iy5A-3ng9A: undetectable 5iy5J-3ng9A: undetectable	5iy5A-3ng9A: 21.77 5iy5J-3ng9A: 7.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_A_EF2A202_0 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.43A	5oh1A-3ng9A: undetectable	5oh1A-3ng9A: 8.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_B_EF2B202_0 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.37A	5oh1B-3ng9A: undetectable	5oh1B-3ng9A: 8.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_A_9V2A202_0 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.42A	5oh3A-3ng9A: undetectable	5oh3A-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_B_9V2B202_0 (CEREBLON ISOFORM 4)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.41A	5oh3B-3ng9A: undetectable	5oh3B-3ng9A: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_A_ACTA309_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 4	LEU A 379 GLY A 275 SER A 261 SER A 262	None	1.19A	5uunA-3ng9A: undetectable	5uunA-3ng9A: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_B_ACTB306_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 4	LEU A 379 GLY A 275 SER A 261 SER A 262	None	1.14A	5uunB-3ng9A: undetectable	5uunB-3ng9A: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.98A	5xdqA-3ng9A: undetectable 5xdqJ-3ng9A: undetectable	5xdqA-3ng9A: 21.77 5xdqJ-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.73A	5xdqN-3ng9A: undetectable 5xdqW-3ng9A: undetectable	5xdqN-3ng9A: 21.77 5xdqW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.88A	5xdxA-3ng9A: undetectable 5xdxJ-3ng9A: undetectable	5xdxA-3ng9A: 21.77 5xdxJ-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.73A	5xdxN-3ng9A: undetectable 5xdxW-3ng9A: undetectable	5xdxN-3ng9A: 21.77 5xdxW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.78A	5zcpN-3ng9A: undetectable 5zcpW-3ng9A: undetectable	5zcpN-3ng9A: 21.77 5zcpW-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWD_C_GLYC713_0 (DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	3 / 3	GLN A 298 TYR A 701 ASN A 302	None	1.00A	6dwdC-3ng9A: undetectable	6dwdC-3ng9A: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NJ9_K_SAMK500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	5 / 12	GLY A 616 GLY A 637 ALA A 620 PHE A 416 PHE A 307	None	0.95A	6nj9K-3ng9A: undetectable	6nj9K-3ng9A: 19.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.91A	6nmfA-3ng9A: undetectable 6nmfJ-3ng9A: undetectable	6nmfA-3ng9A: 21.77 6nmfJ-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.96A	6nmpA-3ng9A: undetectable 6nmpJ-3ng9A: undetectable	6nmpA-3ng9A: 21.77 6nmpJ-3ng9A: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ng9	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 5	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.85A	6nmpN-3ng9A: undetectable 6nmpW-3ng9A: undetectable	6nmpN-3ng9A: 21.77 6nmpW-3ng9A: 7.23

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1V54_W_CHDW4060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.83A","1v54N-3ng9A:undetectable;1v54W-3ng9A:undetectable","1v54N-3ng9A:21.77;1v54W-3ng9A:7.23"],["1VIF_A_FOLA1_0","DIHYDROFOLATE REDUCTASE","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",3,"GLN A 259;ILE A 260;TYR A 276","None","0.72A","1vifA-3ng9A:undetectable","1vifA-3ng9A:6.51"],["2DYR_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.87A","2dyrN-3ng9A:undetectable;2dyrW-3ng9A:undetectable","2dyrN-3ng9A:21.77;2dyrW-3ng9A:7.23"],["2EIJ_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.85A","2eijN-3ng9A:undetectable;2eijW-3ng9A:undetectable","2eijN-3ng9A:21.77;2eijW-3ng9A:7.23"],["2EIK_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.92A","2eikN-3ng9A:undetectable;2eikW-3ng9A:undetectable","2eikN-3ng9A:21.77;2eikW-3ng9A:7.23"],["2EIL_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.91A","2eilN-3ng9A:undetectable;2eilW-3ng9A:undetectable","2eilN-3ng9A:21.77;2eilW-3ng9A:7.23"],["2PLW_A_SAMA203_1","RIBOSOMAL RNA METHYLTRANSFERASE, PUTATIVE","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",3,"SER A 526;ASP A 529;ASP A 532","None","0.79A","2plwA-3ng9A:undetectable","2plwA-3ng9A:13.82"],["2VQY_A_PARA1201_2","AAC(6')-IB","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",3,"TRP A 280;GLN A 646;TRP A 247","None","1.37A","2vqyA-3ng9A:undetectable","2vqyA-3ng9A:13.44"],["3ABL_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.91A","3ablA-3ng9A:undetectable;3ablJ-3ng9A:undetectable","3ablA-3ng9A:21.77;3ablJ-3ng9A:7.23"],["3ABL_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.93A","3ablN-3ng9A:undetectable;3ablW-3ng9A:undetectable","3ablN-3ng9A:21.77;3ablW-3ng9A:7.23"],["3AG3_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.89A","3ag3A-3ng9A:undetectable;3ag3J-3ng9A:undetectable","3ag3A-3ng9A:21.77;3ag3J-3ng9A:7.23"],["3ASN_W_CHDW1059_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.87A","3asnN-3ng9A:undetectable;3asnW-3ng9A:undetectable","3asnN-3ng9A:21.77;3asnW-3ng9A:7.23"],["3WRK_D_CAMD502_0","CAMPHOR 5-MONOOXYGENASE","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PHE A 292;LEU A 687;GLY A 306;VAL A 612","None","1.04A","3wrkD-3ng9A:undetectable","3wrkD-3ng9A:18.78"],["4M2V_A_BZ1A302_1","CARBONIC ANHYDRASE 2","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",5,"LEU A 355;GLN A 646;VAL A 354;GLY A 361;THR A 278","None","0.94A","4m2vA-3ng9A:undetectable","4m2vA-3ng9A:14.89"],["4V2Y_A_EF2A151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.41A","4v2yA-3ng9A:undetectable","4v2yA-3ng9A:11.35"],["4V2Y_B_EF2B151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.41A","4v2yB-3ng9A:undetectable","4v2yB-3ng9A:11.35"],["4V2Z_A_Y70A151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.43A","4v2zA-3ng9A:undetectable","4v2zA-3ng9A:11.35"],["4V2Z_B_Y70B151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.39A","4v2zB-3ng9A:undetectable","4v2zB-3ng9A:11.35"],["4V30_A_LVYA151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.42A","4v30A-3ng9A:undetectable","4v30A-3ng9A:11.35"],["4V30_B_LVYB151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.33A","4v30B-3ng9A:undetectable","4v30B-3ng9A:11.35"],["5AMH_A_EF2A151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.47A","5amhA-3ng9A:undetectable","5amhA-3ng9A:11.35"],["5AMI_A_EF2A151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.42A","5amiA-3ng9A:undetectable","5amiA-3ng9A:11.35"],["5AMI_B_EF2B151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.44A","5amiB-3ng9A:undetectable","5amiB-3ng9A:11.35"],["5AMJ_A_EF2A151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.42A","5amjA-3ng9A:undetectable","5amjA-3ng9A:11.35"],["5AMJ_B_EF2B151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.40A","5amjB-3ng9A:undetectable","5amjB-3ng9A:11.35"],["5AMK_B_EF2B151_1","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.37A","5amkB-3ng9A:undetectable","5amkB-3ng9A:11.35"],["5B1B_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.85A","5b1bA-3ng9A:undetectable;5b1bJ-3ng9A:undetectable","5b1bA-3ng9A:21.77;5b1bJ-3ng9A:7.23"],["5IY5_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.84A","5iy5A-3ng9A:undetectable;5iy5J-3ng9A:undetectable","5iy5A-3ng9A:21.77;5iy5J-3ng9A:7.18"],["5OH1_A_EF2A202_0","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.43A","5oh1A-3ng9A:undetectable","5oh1A-3ng9A:8.93"],["5OH1_B_EF2B202_0","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.37A","5oh1B-3ng9A:undetectable","5oh1B-3ng9A:8.93"],["5OH3_A_9V2A202_0","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.42A","5oh3A-3ng9A:undetectable","5oh3A-3ng9A:11.35"],["5OH3_B_9V2B202_0","CEREBLON ISOFORM 4","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.41A","5oh3B-3ng9A:undetectable","5oh3B-3ng9A:11.35"],["5UUN_A_ACTA309_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"LEU A 379;GLY A 275;SER A 261;SER A 262","None","1.19A","5uunA-3ng9A:undetectable","5uunA-3ng9A:17.42"],["5UUN_B_ACTB306_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"LEU A 379;GLY A 275;SER A 261;SER A 262","None","1.14A","5uunB-3ng9A:undetectable","5uunB-3ng9A:17.42"],["5XDQ_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.98A","5xdqA-3ng9A:undetectable;5xdqJ-3ng9A:undetectable","5xdqA-3ng9A:21.77;5xdqJ-3ng9A:7.23"],["5XDQ_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.73A","5xdqN-3ng9A:undetectable;5xdqW-3ng9A:undetectable","5xdqN-3ng9A:21.77;5xdqW-3ng9A:7.23"],["5XDX_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.88A","5xdxA-3ng9A:undetectable;5xdxJ-3ng9A:undetectable","5xdxA-3ng9A:21.77;5xdxJ-3ng9A:7.23"],["5XDX_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.73A","5xdxN-3ng9A:undetectable;5xdxW-3ng9A:undetectable","5xdxN-3ng9A:21.77;5xdxW-3ng9A:7.23"],["5ZCP_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.78A","5zcpN-3ng9A:undetectable;5zcpW-3ng9A:undetectable","5zcpN-3ng9A:21.77;5zcpW-3ng9A:7.23"],["6DWD_C_GLYC713_0","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",3,"GLN A 298;TYR A 701;ASN A 302","None","1.00A","6dwdC-3ng9A:undetectable","6dwdC-3ng9A:21.18"],["6NJ9_K_SAMK500_0","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",5,"GLY A 616;GLY A 637;ALA A 620;PHE A 416;PHE A 307","None","0.95A","6nj9K-3ng9A:undetectable","6nj9K-3ng9A:19.16"],["6NMF_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.91A","6nmfA-3ng9A:undetectable;6nmfJ-3ng9A:undetectable","6nmfA-3ng9A:21.77;6nmfJ-3ng9A:7.23"],["6NMP_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.96A","6nmpA-3ng9A:undetectable;6nmpJ-3ng9A:undetectable","6nmpA-3ng9A:21.77;6nmpJ-3ng9A:7.23"],["6NMP_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ng9","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.85A","6nmpN-3ng9A:undetectable;6nmpW-3ng9A:undetectable","6nmpN-3ng9A:21.77;6nmpW-3ng9A:7.23"]]